High colloid oncotic therapy for contusional brain edema
- PMID: 7976645
- DOI: 10.1007/978-3-7091-9334-1_151
High colloid oncotic therapy for contusional brain edema
Abstract
We investigated whether prolonged high colloid oncotic therapy for two weeks can suppress contusional brain edema. Eighteen patients with cerebral contusion were randomly divided into two groups of patients receiving high oncotic pressure (HOP; 26-30 mmHg) treatment and those receiving normal oncotic pressure (NOP; 22-26 mmHg) treatment. Oncotic pressure was maintained for two weeks with administration of a 25% albumin solution with additional use of furosemide. Edema volume was calculated by summation of all measured low-density areas in each CT slice multiplied by 1.0 cm of slice of thickness. We expressed contusional brain edema volume as a percent increase based on each patient's initial CT. The mean percent increase of contusional brain edema in the NOP group was significantly higher than that in the HOP group at 9-15 days (208.9% and 14.0%, respectively) and 16-25 days (188.8% and 10.0%, respectively). There were no complications such as heart failure or renal failure during treatment. All the patients in the HOP group recovered with minimal or no neurological deficit. On the other hand, 30% of patients in the NOP group remained in poor condition. With frequent measurement of oncotic pressure and adjustment of fluids and electrolytes, continuous oncotic therapy for two weeks effectively and safely reduced contusional brain edema.
Similar articles
-
High colloid oncotic therapy for brain edema with cerebral hemorrhage.Acta Neurochir Suppl (Wien). 1994;60:568-70. doi: 10.1007/978-3-7091-9334-1_157. Acta Neurochir Suppl (Wien). 1994. PMID: 7976652
-
Intracranial and systemic effects of osmotic and oncotic therapy in experimental cerebral edema.J Neurosurg. 1984 Mar;60(3):481-9. doi: 10.3171/jns.1984.60.3.0481. J Neurosurg. 1984. PMID: 6422010
-
Intracranial and systemic effects of hetastarch in experimental cerebral edema.Crit Care Med. 1984 Jun;12(6):496-500. doi: 10.1097/00003246-198406000-00005. Crit Care Med. 1984. PMID: 6202463
-
[Hypertonic solutions and intracranial pressure].Schweiz Med Wochenschr. 1996 Sep 28;126(39):1635-43. Schweiz Med Wochenschr. 1996. PMID: 8927967 Review. French.
-
[Treatment of ischemic cerebral infarct with glycerine].Nervenarzt. 1995 Aug;66(8):596-602. Nervenarzt. 1995. PMID: 7566270 Review. German.
Cited by
-
Human albumin solution for resuscitation and volume expansion in critically ill patients.Cochrane Database Syst Rev. 2011 Nov 9;2011(11):CD001208. doi: 10.1002/14651858.CD001208.pub4. Cochrane Database Syst Rev. 2011. PMID: 22071799 Free PMC article.
-
Use of Hyperoncotic Human Albumin Solution in Severe Traumatic Brain Injury Revisited-A Narrative Review and Meta-Analysis.J Clin Med. 2022 May 9;11(9):2662. doi: 10.3390/jcm11092662. J Clin Med. 2022. PMID: 35566786 Free PMC article. Review.
-
Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design.Neurocrit Care. 2010 Oct;13(2):263-77. doi: 10.1007/s12028-010-9392-8. Neurocrit Care. 2010. PMID: 20535587
-
The "Lund Concept" for the treatment of severe head trauma--physiological principles and clinical application.Intensive Care Med. 2006 Oct;32(10):1475-84. doi: 10.1007/s00134-006-0294-3. Epub 2006 Aug 2. Intensive Care Med. 2006. PMID: 16896859 Review.
-
Physiological and biochemical principles underlying volume-targeted therapy--the "Lund concept".Neurocrit Care. 2005;2(1):83-95. doi: 10.1385/NCC:2:1:083. Neurocrit Care. 2005. PMID: 16174975 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical